Hanmi Pharmaceutical Company Limited

This study is testing whether taking two oral drugs together, belvarafenib and cobimetinib, can help control advanced melanoma that has a specific genetic change called an NRAS mutation. It is for adults whose cancer has spread and for whom standard treatments have not worked or …

This study is testing whether a new weekly injection called HM15275 can help adults with obesity or overweight lose weight and is safe to use. About 250 participants without diabetes will receive either the drug or a placebo (inactive shot) for 36 weeks to compare results. The ma…

This is the first human study of a new cancer drug called HM16390, testing it both alone and combined with an existing immunotherapy (pembrolizumab). The trial aims to find safe doses and see if the treatment helps patients with advanced solid tumors that have stopped responding …

This is the first human study of a new cancer drug called BH3120. Researchers are testing it alone and combined with an existing immunotherapy (pembrolizumab) in 245 patients with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find s…

This study is testing whether an experimental injection called HM15912 is safe and can help adults with short bowel syndrome intestinal failure. Participants will receive either the drug or a placebo for up to 13 months to see if it improves how their bodies absorb nutrients. The…

This is the first study in humans to test the safety of a new experimental injection called HM17321, which is being developed for obesity. About 40 healthy adults will receive a single injection to see how their bodies react and process the drug. The main goal is to check for sid…